Privium Fund Management B.V. / AXSM
Privium Fund Management B.V.’s Axsome Therapeutics Inc. Position
Does Privium Fund Management B.V. own Axsome Therapeutics Inc. (AXSM)? Yes — 58.7K shares worth $10M (+2.07% of its 13F portfolio) as of Q1 2026, up from 56.9K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
58.7K
% of Portfolio
+2.07%
Quarters Held
13
currently held
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 58.7K | $10M | +2.07% |
| Q4 2025 | 56.9K | $10M | +1.91% |
| Q3 2025 | 52.7K | $6M | +1.15% |
| Q2 2025 | 52.7K | $5M | +1.17% |
| Q1 2025 | 52.7K | $6M | +1.60% |
| Q4 2024 | 62.2K | $5M | +1.19% |
| Q3 2024 | 80.2K | $7M | +1.79% |
| Q2 2024 | 74.3K | $6M | +1.50% |
| Q1 2024 | 82.0K | $7M | +1.75% |
| Q4 2023 | 72.0K | $6M | +1.55% |
| Q3 2023 | 72.0K | $5M | +1.50% |
| Q2 2023 | 72.0K | $5M | +1.52% |
| Q1 2023 | 159.5K | $10M | +3.30% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of AXSM.